Amazon.com Inc founder and CEO Jeff Bezos announced that Andy Jassy, who currently manages the company’s cloud-computing business, will take over the CEO role on July 5.
Bezos said that July 5 was sentimental for him as it was Amazon's incorporation date in 1994.
Amazon.com Inc had announced that Bezos was stepping down as CEO in February, though no specific date was provided.
Bezos, 57, will become the executive chair at Amazon and focus on new products and initiatives.
He would also allocate time to his other ventures, such as his newspaper, The Washington Post, and his rocket ship company, Blue Origin.
The Seattle-based Amazon also announced it would acquire Hollywood studio MGM for $8.45 billion, eyeing to fill its video streaming service with more movies and shows.


Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Asian Stocks Slip as Oil Prices Surge and Fed Signals Inflation Risks
China Factory Activity Extends Growth in April Despite Global Pressures
US Stock Futures Mixed as Fed Holds Rates, Oil Prices Surge, and Big Tech Earnings Drive Market Moves
Dollar Holds Near Two-Week High as Fed Hawkish Shift Lifts Yields, Yen Near Intervention Zone
Oil Prices Ease but Remain Set for Strong April Gains Amid Middle East Tensions
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Gold Prices Dip Ahead of Fed Decision Amid Rising Middle East Tensions
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
US-Iran Conflict Escalates Amid Oil Blockade and Rising Global Tensions
China Manufacturing PMI Beats Forecasts in April Amid Weak Domestic Demand
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
Oil Prices Surge Amid U.S.-Iran Tensions and Supply Disruption Fears
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



